Literature DB >> 16574654

NAB2 represses transcription by interacting with the CHD4 subunit of the nucleosome remodeling and deacetylase (NuRD) complex.

Rajini Srinivasan1, Gennifer M Mager, Rebecca M Ward, Joshua Mayer, John Svaren.   

Abstract

Early growth response (EGR) transactivators act as critical regulators of several physiological processes, including peripheral nerve myelination and progression of prostate cancer. The NAB1 and NAB2 (NGFI-A/EGR1-binding protein) transcriptional corepressors directly interact with three EGR family members (Egr1/NGFI-A/zif268, Egr2/Krox20, and Egr3) and repress activation of their target promoters. To understand the molecular mechanisms underlying NAB repression, we found that EGR activity is modulated by at least two repression domains within NAB2, one of which uniquely requires interaction with the CHD4 (chromodomain helicase DNA-binding protein 4) subunit of the NuRD (nucleosome remodeling and deacetylase) chromatin remodeling complex. Both NAB proteins can bind either CHD3 or CHD4, indicating that the interaction is conserved among these two protein families. Furthermore, we show that repression of the endogenous Rad gene by NAB2 involves interaction with CHD4 and demonstrate colocalization of NAB2 and CHD4 on the Rad promoter in myelinating Schwann cells. Finally, we show that interaction with CHD4 is regulated by alternative splicing of the NAB2 mRNA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16574654     DOI: 10.1074/jbc.M600775200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

Review 1.  Early growth response transcription factors: key mediators of fibrosis and novel targets for anti-fibrotic therapy.

Authors:  Swati Bhattacharyya; Minghua Wu; Feng Fang; Warren Tourtellotte; Carol Feghali-Bostwick; John Varga
Journal:  Matrix Biol       Date:  2011-04-13       Impact factor: 11.583

Review 2.  CHD chromatin remodelers and the transcription cycle.

Authors:  Magdalena Murawska; Alexander Brehm
Journal:  Transcription       Date:  2011-11-01

3.  The nucleosome remodeling and deacetylase chromatin remodeling (NuRD) complex is required for peripheral nerve myelination.

Authors:  Holly Hung; Rebecca Kohnken; John Svaren
Journal:  J Neurosci       Date:  2012-02-01       Impact factor: 6.167

4.  High Expression of miR-532-5p, a Tumor Suppressor, Leads to Better Prognosis in Ovarian Cancer Both In Vivo and In Vitro.

Authors:  Fan Wang; Jeremy T-H Chang; Chester Jingshiu Kao; R Stephanie Huang
Journal:  Mol Cancer Ther       Date:  2016-02-12       Impact factor: 6.261

5.  Tumor suppression by the EGR1, DMP1, ARF, p53, and PTEN Network.

Authors:  Kazushi Inoue; Elizabeth A Fry
Journal:  Cancer Invest       Date:  2018-11-05       Impact factor: 2.176

6.  Pulse sensitivity of the luteinizing hormone beta promoter is determined by a negative feedback loop Involving early growth response-1 and Ngfi-A binding protein 1 and 2.

Authors:  Mark A Lawson; Rie Tsutsumi; Hao Zhang; Indrani Talukdar; Brian K Butler; Sharon J Santos; Pamela L Mellon; Nicholas J G Webster
Journal:  Mol Endocrinol       Date:  2007-02-13

7.  Significance of heparanase in cancer and inflammation.

Authors:  Israel Vlodavsky; Phillip Beckhove; Immanuel Lerner; Claudio Pisano; Amichai Meirovitz; Neta Ilan; Michael Elkin
Journal:  Cancer Microenviron       Date:  2011-08-03

8.  Active gene repression by the Egr2.NAB complex during peripheral nerve myelination.

Authors:  Gennifer M Mager; Rebecca M Ward; Rajini Srinivasan; Sung-Wook Jang; Lawrence Wrabetz; John Svaren
Journal:  J Biol Chem       Date:  2008-05-02       Impact factor: 5.157

9.  Vascular endothelial growth factor activation of endothelial cells is mediated by early growth response-3.

Authors:  Jun-ichi Suehiro; Takao Hamakubo; Tatsuhiko Kodama; William C Aird; Takashi Minami
Journal:  Blood       Date:  2009-11-23       Impact factor: 22.113

10.  Transcription factor early growth response-1 induction mediates inflammatory gene expression and brain damage following transient focal ischemia.

Authors:  Kudret Tureyen; Nathaniel Brooks; Kellie Bowen; John Svaren; Raghu Vemuganti
Journal:  J Neurochem       Date:  2008-01-16       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.